JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on January 14, 2004; DOI: 10.1124/jpet.103.064808


0022-3565/04/3092-476-483$20.00
JPET 309:476-483, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.064808v1
309/2/476    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Finnegan, T. F.
Right arrow Articles by Pan, H.-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Finnegan, T. F.
Right arrow Articles by Pan, H.-L.

NEUROPHARMACOLOGY

Activation of µ-Opioid Receptors Inhibits Synaptic Inputs to Spinally Projecting Rostral Ventromedial Medulla Neurons

Thomas F. Finnegan, De-Pei Li, Shao-Rui Chen, and Hui-Lin Pan

Department of Anesthesiology, The Pennsylvania State University College of Medicine, The Milton S. Hershey Medical Center, Hershey, Pennsylvania

The rostral ventromedial medulla (RVM) is a major locus for the descending control of nociception and opioid analgesia. However, it is not clear how opioids affect synaptic inputs to RVM neurons. In this study, we determined the effect of µ-opioid receptor activation on excitatory and inhibitory synaptic transmission in spinally projecting RVM neurons. RVM neurons were retrogradely labeled with a fluorescent tracer injected into the dorsal horn of the spinal cord in rats. Whole-cell voltage-clamp recordings were performed on labeled RVM neurons in brain slices in vitro. The µ-receptor agonist [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin (DAMGO, 1 µM) significantly decreased the amplitude of evoked excitatory postsynaptic currents (EPSCs) in 52% (9 of 17) of labeled cells. DAMGO also significantly reduced the amplitude of evoked inhibitory postsynaptic currents (IPSCs) in 69% (11 of 16) of cells examined. Furthermore, DAMGO significantly decreased the frequency of miniature EPSCs in 55% (15 of 27) of cells and significantly decreased the frequency of miniature IPSCs in all 12 cells studied. Although most EPSCs and IPSCs were mediated by glutamate and GABA, the nicotinic and glycine receptor antagonists attenuated EPSCs and IPSCs, respectively, in some labeled RVM neurons. Immunocytochemical labeling revealed that only 35% of recorded RVM neurons were tryptophan hydroxylase-positive, and 15% cells had GABA immunoreactivity. Thus, this study provides important functional evidence that activation of µ-opioid receptors decreases the release of both excitatory and inhibitory neurotransmitters onto most spinally projecting RVM neurons.


Received for publication December 22, 2003
Accepted December 31, 2003.

Address correspondence to: Dr. Hui-Lin Pan, Department of Anesthesiology, H187, The Pennsylvania State University College of Medicine, 500 University Dr., Hershey, PA 17033-0850. E-mail: hpan{at}psu.edu




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
K. T. Sykes, S. R. White, R. W. Hurley, H. Mizoguchi, L. F. Tseng, and D. L. Hammond
Mechanisms Responsible for the Enhanced Antinociceptive Effects of {micro}-Opioid Receptor Agonists in the Rostral Ventromedial Medulla of Male Rats with Persistent Inflammatory Pain
J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 813 - 821.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
P. Sah
Canonical Organization of Opioid Modulation of Nociceptive Circuits. Focus on "{micro} Opioid Receptor Activation Inhibits GABAergic Inputs to Basolateral Amygdala Neurons Through Kv1.1/Kv1.2 Channels"
J Neurophysiol, April 1, 2006; 95(4): 2029 - 2030.
[Full Text] [PDF]


Home page
J. Neurophysiol.Home page
T. F. Finnegan, S.-R. Chen, and H.-L. Pan
{micro} Opioid Receptor Activation Inhibits GABAergic Inputs to Basolateral Amygdala Neurons Through Kv1.1/1.2 Channels
J Neurophysiol, April 1, 2006; 95(4): 2032 - 2041.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
L. Zhang, K. T. Sykes, A. V. Buhler, and D. L. Hammond
Electrophysiological Heterogeneity of Spinally Projecting Serotonergic and Nonserotonergic Neurons in the Rostral Ventromedial Medulla
J Neurophysiol, March 1, 2006; 95(3): 1853 - 1863.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. F. Finnegan, S.-R. Chen, and H.-L. Pan
Effect of the {micro} Opioid on Excitatory and Inhibitory Synaptic Inputs to Periaqueductal Gray-Projecting Neurons in the Amygdala
J. Pharmacol. Exp. Ther., February 1, 2005; 312(2): 441 - 448.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
D.-P. Li, L. M. Atnip, S.-R. Chen, and H.-L. Pan
Regulation of Synaptic Inputs to Paraventricular-Spinal Output Neurons by {alpha}2 Adrenergic Receptors
J Neurophysiol, January 1, 2005; 93(1): 393 - 402.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.